Four rules of hepatitis B medication

  Pay attention to the safety of
  the treatment of hepatitis B drug first to emphasize safety, hepatitis B patient’s condition is easy to change, long course of treatment, it is difficult to single drug for therapeutic purposes, to use more combination therapy, medication safety is paramount. A variety of hepatitis medications that have been used many years ago have been shown to be unsafe, such as adenosine monophosphate, foscarnet, etc., which may cause kidney damage. Currently used interferon, lamivudine, etc., also have serious safety hazards, which may lead to exacerbation if improperly used, improperly selected, or arbitrarily stopped.
  Chinese medicine also has insecurities. Some Chinese medicines and traditional Chinese medicine preparations have been confirmed to have obvious liver damage effects, such as Chinese medicine Xanthium, Guanzhong, Tripterygium wilfordii, and Tianhua powder, Chinese medicine Xiaochaihu Tang and Fufang Qinglan Pill. Therefore, to avoid abuse, it must be used with caution for folk prescriptions and remedies to prevent poisoning. Patients with a history of drug allergy or allergies, once drug-induced liver damage occurs, must stop using the drug and go to the regular hospital for treatment.
  The pursuit of the effectiveness of
  many old and hepatitis B drug has been gradually phased out. At present, as the main drug for the treatment of hepatitis B, anti-hepatitis B virus drugs, only interferon, lamivudine, etc. are recognized. Other drugs that have anti-hepatitis B virus properties have not been unanimously recognized.
  Promote economic
  treatment of hepatitis B is expensive, expensive drugs is well known, the hepatitis B patient’s condition capricious, often have long-term medication, many patients impoverished. Therefore, patients with hepatitis B must be carefully counted and spend less. For example, there are many drugs that have the effect of protecting liver and reducing enzymes. When choosing a drug, you must consider the affordability and choose a cheap and good drug, such as Ganlixin injection.
  The long-term efficacy of many new drugs has not been determined, and the price is very expensive, it is not recommended as a first-line drug recommended.
  Grasp the appropriateness of
  appropriate medication depending on the disease and the body condition of the patient, weigh the pros and cons of a variety of factors, choose the same drugs in the most appropriate medication. For example, in patients with early cirrhosis, the combination of antiviral and anti-fibrotic drugs is the best.
  The appropriate dose of interferon for the treatment of hepatitis B is very common, but the dose is very particular. If the dose is too small, it is difficult to work; the dose is too large, the side effects of the drug are too strong, and the patient’s body is unbearable.
  Appropriate time, such as long-acting interferon once a week, ensures that the drug concentration in the patient’s blood remains within the effective range within a week, reducing pain and trouble for the patient.
  The appropriate route of administration must take into account the purpose of the drug, the nature of the drug, the physical condition of the patient, and the factors such as safety, economy, and convenience. Oral administration is both convenient and economical, and patients suffer less. On the contrary, intravenous drip is not recommended for easy use.
  Appropriate patient treatment of hepatitis B emphasizes the principle of individualization and treatment according to humans. For example, patients who are treated with interferon must have patients with elevated transaminase and positive hepatitis B virus replication; patients with severe or severe hepatitis B should not be treated with interferon. .
  The appropriate course of treatment defines the period of drug treatment according to the principles of treatment. Anti-hepatitis B virus treatment and anti-fibrosis treatment are long-term persistence. When the curative effect is obvious, the drug can not be stopped without authorization, and the treatment should be extended if necessary to obtain a stable and lasting effect. For example, treatment of hepatitis B with lamivudine and interferon requires more than one year of treatment. Some drugs are not suitable for long-term use, to avoid prolonged drug delivery time, reduce the occurrence of adverse reactions such as accumulation of poisoning, viral resistance, drug dependence. For example, if a patient with hepatitis B has a cold and fever, the use of anti-inflammatory drugs must adopt the principle of “short and fast” to eliminate the drug.